Generics Industry Sounds Alarm Over Northern Ireland Requirements As Deadline Looms

‘UK Only’ Labeling And Biological Testing Threaten Supply Ahead Of 1 January 2025

With a looming deadline of 1 January 2025 for firms supplying Northern Ireland to comply with the Windsor Framework, UK generics and biosimilars association the BGMA has warned of potential supply interruptions due to requirements that include a “UK only” label for all packs as well as UK-based batch testing for biologicals.

The BGMA says Windsor Framework requirements put supply at risk (Shutterstock)

More from Biosimilars & Generics

More from United Kingdom